https://www.selleckchem.com/pr....oducts/ademetionine.
97 to 2.27 (p .0001) and time from CIC to leakage increased from 1.73 hto 2.75 h (p .0001). The mean cystometric capacity increased from 348 ml to 406 ml (p = .008) and the maximum amplitude of NDO decreased from 54 cm H O to 41 cm H O(p = .005) at 6 weeks. Only two patients reported new onset dry mouth. No major adverse events were noted and none discontinued treatment. Mirabegron is efficacious and safe in patients with NDO consequent to traumatic SCI. Mirabegron is efficacious and safe in patients with NDO consequent t
Like
Comment
Share
